|
|
||||||||
SCIENTIFIC EXHIBIT |
1 Departments of Radiology (K.M.H., D.A.B., E.K.F.)
2 Pathology (R.H.H.), Johns Hopkins Hospital, Baltimore, Md
3 Department of Body and Vascular Imaging, Hospital Lariboisiere, Paris, France (P.S.)
Benign hepatic and biliary tumors can present a difficult diagnostic challenge. Spiral computed tomography (CT) and magnetic resonance (MR) imaging are useful in the detection and characterization of these tumors. Imaging characteristics of lesions such as hepatic cyst, hemangioma, focal nodular hyperplasia (FNH), and hepatic adenoma are well known. Hepatic cysts demonstrate water attenuation at CT, are isointense relative to water at MR imaging, and do not enhance after intravenous administration of contrast material. Hemangiomas demonstrate characteristic nodular peripheral enhancement on early-phase images with subsequent fill-in centrally at both modalities. FNH classically demonstrates intense early enhancement with washout on delayed images. Although hepatic adenoma can also demonstrate intense early enhancement, it has a tendency to bleed and thus often appears more heterogeneous than FNH due to hemorrhage. Benign hepatic tumors that are less well described in the imaging literature include hepatic lipoma or angiomyolipoma, infantile hemangioendothelioma, and mesenchymal hamartoma. Hepatic lipoma has fat attenuation at CT, is isointense relative to fat at MR imaging, and does not enhance after intravenous administration of contrast material. Hepatic angiomyolipomas contain a variable amount of soft tissue in addition to fat and may therefore demonstrate enhancement at both modalities. The CT and MR imaging appearances of infantile hemangioma are similar to those of adult hemangioma. Infantile hemangioendothelioma occurs in infants under 6 months of age and is typically a larger lesion. Mesenchymal hamartoma also occurs in children, and its imaging appearance depends on the presence of stromal elements and the protein content of the cyst fluid. Familiarity with these imaging features can help distinguish particular disease entities.
Index Terms: Bile ducts, CT, 76.1211 Bile ducts, MR, 76.1214 Bile ducts, neoplasms, 76.31 Liver neoplasms, 761.31 Liver neoplasms, CT, 761.1211 Liver neoplasms, diagnosis, 761.1211, 761.1214 Liver neoplasms, MR, 761.1214
This article has been cited by other articles:
![]() |
H.-X. Xu, X.-Y. Xie, M.-D. Lu, G.-J. Liu, Z.-F. Xu, J.-Y. Liang, and L.-D. Chen Unusual Benign Focal Liver Lesions: Findings on Real-time Contrast-Enhanced Sonography J. Ultrasound Med., February 1, 2008; 27(2): 243 - 254. [Abstract] [Full Text] [PDF] |
||||
![]() |
E-Y CHA, K W KIM, Y J CHOI, J S SONG, K J CHO, and M-G LEE Multicystic cavernous haemangioma of the liver: ultrasonography, CT, MR appearances and pathological correlation Br. J. Radiol., February 1, 2008; 81(962): e37 - e39. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Kim, K. W. Kim, S. H. Park, S. J. Jang, M.-S. Park, P. N. Kim, M.-G. Lee, and H. K. Ha Unusual mesenchymal liver tumors in adults: radiologic-pathologic correlation. Am. J. Roentgenol., November 1, 2006; 187(5): W481 - W489. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Gandhi, M. A. Brown, J. G. Wong, D. A. Aguirre, and C. B. Sirlin MR Contrast Agents for Liver Imaging: What, When, How RadioGraphics, November 1, 2006; 26(6): 1621 - 1636. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Onishi, T. Murakami, T. Kim, M. Hori, R. Iannaccone, M. Kuwabara, H. Abe, S. Nakata, K. Osuga, K. Tomoda, et al. Hepatic Metastases: Detection with Multi-Detector Row CT, SPIO-enhanced MR Imaging, and Both Techniques Combined Radiology, April 1, 2006; 239(1): 131 - 138. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Elsayes, V. R. Narra, Y. Yin, G. Mukundan, M. Lammle, and J. J. Brown Focal Hepatic Lesions: Diagnostic Value of Enhancement Pattern Approach with Contrast-enhanced 3D Gradient-Echo MR Imaging RadioGraphics, September 1, 2005; 25(5): 1299 - 1320. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Grazioli, G. Morana, M. A. Kirchin, and G. Schneider Accurate Differentiation of Focal Nodular Hyperplasia from Hepatic Adenoma at Gadobenate Dimeglumine-enhanced MR Imaging: Prospective Study Radiology, July 1, 2005; 236(1): 166 - 177. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Basaran, M. Karcaaltincaba, D. Akata, N. Karabulut, D. Akinci, M. Ozmen, and O. Akhan Fat-Containing Lesions of the Liver: Cross-Sectional Imaging Findings with Emphasis on MRI Am. J. Roentgenol., April 1, 2005; 184(4): 1103 - 1110. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. von Herbay, C. Vogt, R. Willers, and D. Haussinger Real-time Imaging With the Sonographic Contrast Agent SonoVue: Differentiation Between Benign and Malignant Hepatic Lesions J. Ultrasound Med., December 1, 2004; 23(12): 1557 - 1568. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gallego, M. Miralles, C. Marin, P. Muyor, G. Gonzalez, and E. Garcia-Hidalgo Congenital Hepatic Shunts RadioGraphics, May 1, 2004; 24(3): 755 - 772. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Roos, R. Pfiffner, T. Stallmach, G. Stuckmann, B. Marincek, and U. Willi Infantile Hemangioendothelioma RadioGraphics, November 1, 2003; 23(6): 1649 - 1655. [Full Text] [PDF] |
||||
![]() |
N. H. Theumann, J. Bittoun, S. Goettmann, D. Le Viet, A. Chevrot, and J.-L. Drapé Hemangiomas of the Fingers: MR Imaging Evaluation Radiology, March 1, 2001; 218(3): 841 - 847. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOGRAPHICS | RADIOLOGY | RSNA JOURNALS ONLINE |